Control Bionics Ltd (CBL)

Sydney
0.205
0.000(0.00%)
  • Volume:
    0
  • Bid/Ask:
    0.205/0.255
  • Day's Range:
    0.205 - 0.205

CBL Overview

Prev. Close
0.21
Day's Range
0.205-0.205
Revenue
4.51M
Open
0.205
52 wk Range
0.115-0.745
EPS
-0.1
Volume
0
Market Cap
18.55M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
100,921
P/E Ratio
-
Beta
-
1-Year Change
-69.4%
Shares Outstanding
90,479,028
Next Earnings Date
-
What is your sentiment on Control Bionics?
or
Vote to see community's results!

Control Bionics Ltd News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade

Control Bionics Ltd Company Profile

Control Bionics Ltd Company Profile

Control Bionics Limited is a technology company. The Company is principally engaged in development, commercialization and sale of assistive communications technology systems namely NeuroNode within the disability sector. The Group’s core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment and external control of other devices. Its NeuroNode Trilogy system combines its NeuroNode with eye-gaze technology to create a communication system. Its NeuroNode3 combines the NeuroNode wearable device with operating systems and is suitable for users with severe impairment. Its geographical locations consist of Australia, which is engaged in sales of Trilogy units and components in Australia, and North America, which is engaged in manufacturing and sales of Trilogy units and components in North America.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsSellSellNeutralSellStrong Sell
SummarySellSellNeutralStrong SellStrong Sell
  • cbl is now called Control Bionics
    0